PMC:7212965 / 85047-86237 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T204","span":{"begin":524,"end":529},"obj":"Body_part"}],"attributes":[{"id":"A204","pred":"fma_id","subj":"T204","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":" Nobel, 202047New York–Presbyterian Hospital/Columbia University Irving Medical CenterNew YorkDates: 3/10/2020-3/21/2020Last follow-up: 18 days after testing n = 278Survival: 3.2% died,Inclusion: Patients tested for COVID-19 at clinic or emergency department for respiratory symptoms with intent to hospitalize or the same symptoms in essential personnel. Excluded patients with insufficient data (42). Charts randomly selected.Age: 11% aged 18–30 y, 25% aged 31–50 y, 37% aged 51–70 y, and 27% aged \u003e70 ySex: 48% femalesGI/liver comorbidities: NRDisease severity: 74.5% admitted to hospital, 15.8% admitted to ICU, 3.2% died. Diarrhea: 20.1% (56)Present on admission42/207 admitted to hospital, 11/44 admitted to ICU, 0/9 died.Vomiting/vomiting: 22.7% (63)Present on admission51/207 admitted to hospital, 8/44 admitted to ICU, 0/9 died.Abdominal pain: NR35% had GI symptoms. Patients with GI symptoms were more likely to have illness duration of ≥1 week (33%) compared to patients without symptoms (22%).Presence of GI symptoms (diarrhea or nausea/vomiting) was associated with a 70% increased risk of testing positive (adjusted odds ratio 1.7; 95% CI, 1.1–2.5) AST: NRALT: NRBilirubin: NR"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T168","span":{"begin":524,"end":529},"obj":"Body_part"}],"attributes":[{"id":"A168","pred":"uberon_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":" Nobel, 202047New York–Presbyterian Hospital/Columbia University Irving Medical CenterNew YorkDates: 3/10/2020-3/21/2020Last follow-up: 18 days after testing n = 278Survival: 3.2% died,Inclusion: Patients tested for COVID-19 at clinic or emergency department for respiratory symptoms with intent to hospitalize or the same symptoms in essential personnel. Excluded patients with insufficient data (42). Charts randomly selected.Age: 11% aged 18–30 y, 25% aged 31–50 y, 37% aged 51–70 y, and 27% aged \u003e70 ySex: 48% femalesGI/liver comorbidities: NRDisease severity: 74.5% admitted to hospital, 15.8% admitted to ICU, 3.2% died. Diarrhea: 20.1% (56)Present on admission42/207 admitted to hospital, 11/44 admitted to ICU, 0/9 died.Vomiting/vomiting: 22.7% (63)Present on admission51/207 admitted to hospital, 8/44 admitted to ICU, 0/9 died.Abdominal pain: NR35% had GI symptoms. Patients with GI symptoms were more likely to have illness duration of ≥1 week (33%) compared to patients without symptoms (22%).Presence of GI symptoms (diarrhea or nausea/vomiting) was associated with a 70% increased risk of testing positive (adjusted odds ratio 1.7; 95% CI, 1.1–2.5) AST: NRALT: NRBilirubin: NR"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T397","span":{"begin":216,"end":224},"obj":"Disease"},{"id":"T398","span":{"begin":627,"end":635},"obj":"Disease"},{"id":"T399","span":{"begin":1030,"end":1038},"obj":"Disease"}],"attributes":[{"id":"A397","pred":"mondo_id","subj":"T397","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A398","pred":"mondo_id","subj":"T398","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A399","pred":"mondo_id","subj":"T399","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":" Nobel, 202047New York–Presbyterian Hospital/Columbia University Irving Medical CenterNew YorkDates: 3/10/2020-3/21/2020Last follow-up: 18 days after testing n = 278Survival: 3.2% died,Inclusion: Patients tested for COVID-19 at clinic or emergency department for respiratory symptoms with intent to hospitalize or the same symptoms in essential personnel. Excluded patients with insufficient data (42). Charts randomly selected.Age: 11% aged 18–30 y, 25% aged 31–50 y, 37% aged 51–70 y, and 27% aged \u003e70 ySex: 48% femalesGI/liver comorbidities: NRDisease severity: 74.5% admitted to hospital, 15.8% admitted to ICU, 3.2% died. Diarrhea: 20.1% (56)Present on admission42/207 admitted to hospital, 11/44 admitted to ICU, 0/9 died.Vomiting/vomiting: 22.7% (63)Present on admission51/207 admitted to hospital, 8/44 admitted to ICU, 0/9 died.Abdominal pain: NR35% had GI symptoms. Patients with GI symptoms were more likely to have illness duration of ≥1 week (33%) compared to patients without symptoms (22%).Presence of GI symptoms (diarrhea or nausea/vomiting) was associated with a 70% increased risk of testing positive (adjusted odds ratio 1.7; 95% CI, 1.1–2.5) AST: NRALT: NRBilirubin: NR"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T649","span":{"begin":136,"end":138},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T650","span":{"begin":150,"end":157},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T651","span":{"begin":205,"end":211},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T652","span":{"begin":433,"end":435},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T653","span":{"begin":442,"end":444},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T654","span":{"begin":491,"end":493},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T655","span":{"begin":510,"end":512},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T656","span":{"begin":524,"end":529},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T657","span":{"begin":524,"end":529},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T658","span":{"begin":696,"end":698},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T659","span":{"begin":1000,"end":1002},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T660","span":{"begin":1079,"end":1080},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T661","span":{"begin":1103,"end":1110},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":" Nobel, 202047New York–Presbyterian Hospital/Columbia University Irving Medical CenterNew YorkDates: 3/10/2020-3/21/2020Last follow-up: 18 days after testing n = 278Survival: 3.2% died,Inclusion: Patients tested for COVID-19 at clinic or emergency department for respiratory symptoms with intent to hospitalize or the same symptoms in essential personnel. Excluded patients with insufficient data (42). Charts randomly selected.Age: 11% aged 18–30 y, 25% aged 31–50 y, 37% aged 51–70 y, and 27% aged \u003e70 ySex: 48% femalesGI/liver comorbidities: NRDisease severity: 74.5% admitted to hospital, 15.8% admitted to ICU, 3.2% died. Diarrhea: 20.1% (56)Present on admission42/207 admitted to hospital, 11/44 admitted to ICU, 0/9 died.Vomiting/vomiting: 22.7% (63)Present on admission51/207 admitted to hospital, 8/44 admitted to ICU, 0/9 died.Abdominal pain: NR35% had GI symptoms. Patients with GI symptoms were more likely to have illness duration of ≥1 week (33%) compared to patients without symptoms (22%).Presence of GI symptoms (diarrhea or nausea/vomiting) was associated with a 70% increased risk of testing positive (adjusted odds ratio 1.7; 95% CI, 1.1–2.5) AST: NRALT: NRBilirubin: NR"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T198","span":{"begin":863,"end":865},"obj":"Chemical"},{"id":"T199","span":{"begin":890,"end":892},"obj":"Chemical"},{"id":"T200","span":{"begin":1017,"end":1019},"obj":"Chemical"},{"id":"T201","span":{"begin":1163,"end":1166},"obj":"Chemical"},{"id":"T202","span":{"begin":1188,"end":1190},"obj":"Chemical"}],"attributes":[{"id":"A198","pred":"chebi_id","subj":"T198","obj":"http://purl.obolibrary.org/obo/CHEBI_73907"},{"id":"A199","pred":"chebi_id","subj":"T199","obj":"http://purl.obolibrary.org/obo/CHEBI_73907"},{"id":"A200","pred":"chebi_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/CHEBI_73907"},{"id":"A201","pred":"chebi_id","subj":"T201","obj":"http://purl.obolibrary.org/obo/CHEBI_76649"},{"id":"A202","pred":"chebi_id","subj":"T202","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"}],"text":" Nobel, 202047New York–Presbyterian Hospital/Columbia University Irving Medical CenterNew YorkDates: 3/10/2020-3/21/2020Last follow-up: 18 days after testing n = 278Survival: 3.2% died,Inclusion: Patients tested for COVID-19 at clinic or emergency department for respiratory symptoms with intent to hospitalize or the same symptoms in essential personnel. Excluded patients with insufficient data (42). Charts randomly selected.Age: 11% aged 18–30 y, 25% aged 31–50 y, 37% aged 51–70 y, and 27% aged \u003e70 ySex: 48% femalesGI/liver comorbidities: NRDisease severity: 74.5% admitted to hospital, 15.8% admitted to ICU, 3.2% died. Diarrhea: 20.1% (56)Present on admission42/207 admitted to hospital, 11/44 admitted to ICU, 0/9 died.Vomiting/vomiting: 22.7% (63)Present on admission51/207 admitted to hospital, 8/44 admitted to ICU, 0/9 died.Abdominal pain: NR35% had GI symptoms. Patients with GI symptoms were more likely to have illness duration of ≥1 week (33%) compared to patients without symptoms (22%).Presence of GI symptoms (diarrhea or nausea/vomiting) was associated with a 70% increased risk of testing positive (adjusted odds ratio 1.7; 95% CI, 1.1–2.5) AST: NRALT: NRBilirubin: NR"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T389","span":{"begin":627,"end":635},"obj":"Phenotype"},{"id":"T390","span":{"begin":737,"end":745},"obj":"Phenotype"},{"id":"T391","span":{"begin":847,"end":851},"obj":"Phenotype"},{"id":"T392","span":{"begin":1030,"end":1038},"obj":"Phenotype"},{"id":"T393","span":{"begin":1042,"end":1057},"obj":"Phenotype"}],"attributes":[{"id":"A389","pred":"hp_id","subj":"T389","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A390","pred":"hp_id","subj":"T390","obj":"http://purl.obolibrary.org/obo/HP_0002013"},{"id":"A391","pred":"hp_id","subj":"T391","obj":"http://purl.obolibrary.org/obo/HP_0012531"},{"id":"A392","pred":"hp_id","subj":"T392","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A393","pred":"hp_id","subj":"T393","obj":"http://purl.obolibrary.org/obo/HP_0002017"}],"text":" Nobel, 202047New York–Presbyterian Hospital/Columbia University Irving Medical CenterNew YorkDates: 3/10/2020-3/21/2020Last follow-up: 18 days after testing n = 278Survival: 3.2% died,Inclusion: Patients tested for COVID-19 at clinic or emergency department for respiratory symptoms with intent to hospitalize or the same symptoms in essential personnel. Excluded patients with insufficient data (42). Charts randomly selected.Age: 11% aged 18–30 y, 25% aged 31–50 y, 37% aged 51–70 y, and 27% aged \u003e70 ySex: 48% femalesGI/liver comorbidities: NRDisease severity: 74.5% admitted to hospital, 15.8% admitted to ICU, 3.2% died. Diarrhea: 20.1% (56)Present on admission42/207 admitted to hospital, 11/44 admitted to ICU, 0/9 died.Vomiting/vomiting: 22.7% (63)Present on admission51/207 admitted to hospital, 8/44 admitted to ICU, 0/9 died.Abdominal pain: NR35% had GI symptoms. Patients with GI symptoms were more likely to have illness duration of ≥1 week (33%) compared to patients without symptoms (22%).Presence of GI symptoms (diarrhea or nausea/vomiting) was associated with a 70% increased risk of testing positive (adjusted odds ratio 1.7; 95% CI, 1.1–2.5) AST: NRALT: NRBilirubin: NR"}

{"project":"LitCovid-sentences","denotations":[{"id":"T817","span":{"begin":0,"end":100},"obj":"Sentence"},{"id":"T818","span":{"begin":101,"end":135},"obj":"Sentence"},{"id":"T819","span":{"begin":136,"end":174},"obj":"Sentence"},{"id":"T820","span":{"begin":175,"end":195},"obj":"Sentence"},{"id":"T821","span":{"begin":196,"end":355},"obj":"Sentence"},{"id":"T822","span":{"begin":356,"end":402},"obj":"Sentence"},{"id":"T823","span":{"begin":403,"end":432},"obj":"Sentence"},{"id":"T824","span":{"begin":433,"end":509},"obj":"Sentence"},{"id":"T825","span":{"begin":510,"end":564},"obj":"Sentence"},{"id":"T826","span":{"begin":565,"end":626},"obj":"Sentence"},{"id":"T827","span":{"begin":627,"end":636},"obj":"Sentence"},{"id":"T828","span":{"begin":637,"end":746},"obj":"Sentence"},{"id":"T829","span":{"begin":747,"end":875},"obj":"Sentence"},{"id":"T830","span":{"begin":876,"end":1190},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Nobel, 202047New York–Presbyterian Hospital/Columbia University Irving Medical CenterNew YorkDates: 3/10/2020-3/21/2020Last follow-up: 18 days after testing n = 278Survival: 3.2% died,Inclusion: Patients tested for COVID-19 at clinic or emergency department for respiratory symptoms with intent to hospitalize or the same symptoms in essential personnel. Excluded patients with insufficient data (42). Charts randomly selected.Age: 11% aged 18–30 y, 25% aged 31–50 y, 37% aged 51–70 y, and 27% aged \u003e70 ySex: 48% femalesGI/liver comorbidities: NRDisease severity: 74.5% admitted to hospital, 15.8% admitted to ICU, 3.2% died. Diarrhea: 20.1% (56)Present on admission42/207 admitted to hospital, 11/44 admitted to ICU, 0/9 died.Vomiting/vomiting: 22.7% (63)Present on admission51/207 admitted to hospital, 8/44 admitted to ICU, 0/9 died.Abdominal pain: NR35% had GI symptoms. Patients with GI symptoms were more likely to have illness duration of ≥1 week (33%) compared to patients without symptoms (22%).Presence of GI symptoms (diarrhea or nausea/vomiting) was associated with a 70% increased risk of testing positive (adjusted odds ratio 1.7; 95% CI, 1.1–2.5) AST: NRALT: NRBilirubin: NR"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2192","span":{"begin":1017,"end":1019},"obj":"Gene"},{"id":"2193","span":{"begin":890,"end":892},"obj":"Gene"},{"id":"2194","span":{"begin":863,"end":865},"obj":"Gene"},{"id":"2273","span":{"begin":196,"end":204},"obj":"Species"},{"id":"2274","span":{"begin":365,"end":373},"obj":"Species"},{"id":"2275","span":{"begin":876,"end":884},"obj":"Species"},{"id":"2276","span":{"begin":973,"end":981},"obj":"Species"},{"id":"2292","span":{"begin":263,"end":274},"obj":"Species"}],"attributes":[{"id":"A2192","pred":"tao:has_database_id","subj":"2192","obj":"Gene:2770"},{"id":"A2193","pred":"tao:has_database_id","subj":"2193","obj":"Gene:2770"},{"id":"A2194","pred":"tao:has_database_id","subj":"2194","obj":"Gene:2770"},{"id":"A2273","pred":"tao:has_database_id","subj":"2273","obj":"Tax:9606"},{"id":"A2274","pred":"tao:has_database_id","subj":"2274","obj":"Tax:9606"},{"id":"A2275","pred":"tao:has_database_id","subj":"2275","obj":"Tax:9606"},{"id":"A2276","pred":"tao:has_database_id","subj":"2276","obj":"Tax:9606"},{"id":"A2292","pred":"tao:has_database_id","subj":"2292","obj":"Tax:12814"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" Nobel, 202047New York–Presbyterian Hospital/Columbia University Irving Medical CenterNew YorkDates: 3/10/2020-3/21/2020Last follow-up: 18 days after testing n = 278Survival: 3.2% died,Inclusion: Patients tested for COVID-19 at clinic or emergency department for respiratory symptoms with intent to hospitalize or the same symptoms in essential personnel. Excluded patients with insufficient data (42). Charts randomly selected.Age: 11% aged 18–30 y, 25% aged 31–50 y, 37% aged 51–70 y, and 27% aged \u003e70 ySex: 48% femalesGI/liver comorbidities: NRDisease severity: 74.5% admitted to hospital, 15.8% admitted to ICU, 3.2% died. Diarrhea: 20.1% (56)Present on admission42/207 admitted to hospital, 11/44 admitted to ICU, 0/9 died.Vomiting/vomiting: 22.7% (63)Present on admission51/207 admitted to hospital, 8/44 admitted to ICU, 0/9 died.Abdominal pain: NR35% had GI symptoms. Patients with GI symptoms were more likely to have illness duration of ≥1 week (33%) compared to patients without symptoms (22%).Presence of GI symptoms (diarrhea or nausea/vomiting) was associated with a 70% increased risk of testing positive (adjusted odds ratio 1.7; 95% CI, 1.1–2.5) AST: NRALT: NRBilirubin: NR"}